Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,203 trials

NCT07079631
Recruiting
A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment Pumitamig (BNT327) and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer
Phase 1/2 · Germany, Spain, United Kingdom, Japan, United States · 14 sites
Registry update: 1 Jul 2026
NCT06950385
Recruiting
Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis
Phase 3 · Germany, Denmark, Spain, Italy, Netherlands, Puerto Rico, United States · 29 sites
Registry update: 2 Jun 2026
NCT06831500
Recruiting
Feasibility Study Assessing the Effect of Carbidopa/Levodopa Ratio on Orthostatic Hypotension in Multiple System Atrophy - Parkinsonian Type and Parkinson Disease.
Phase 1/2 · Switzerland · 2 sites
Registry update: 29 Jan 2026
NCT07093476
Recruiting
Efficacy and Safety of Add-On Therapy With Empagliflozin in Patients With Type 2 Diabetes on a Background of Alogliptin and Metformin
Phase 3 · South Korea · 1 site
Registry update: 11 Aug 2025
NCT07011056
Recruiting
A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma
Phase 3 · China · 1 site
Registry update: 19 Sept 2025
NCT05754840
Recruiting
CANnabinoids in Pediatric ONCology
Phase 1/2 · Canada · 3 sites
Registry update: 11 Jun 2026
NCT07052253
Recruiting
A Phase II Clinical Study of AK104/AK112 in Combination With TT-00420 Tablet for Advanced HCC.
Phase 2 · China · 1 site
Registry update: 16 Mar 2026
NCT06824168
Recruiting
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
Phase 2 · Australia, Brazil, China, South Korea, United States · 63 sites
Registry update: 16 Sept 2026
NCT06779630
Recruiting
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
Not applicable · Austria, Switzerland, Germany, France, Poland, United States · 23 sites
Registry update: 5 Nov 2026
NCT06953089
Recruiting
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Phase 2 · Australia, China, Germany, Spain, France, Italy, Poland, Taiwan, United States · 60 sites
Registry update: 29 Oct 2026
NCT06362161
Recruiting
Establishment of an Interdisciplinary Functional Neurological Disorder (FND) Treatment Program and Development of a Clinical Care Pathway for FND
Not applicable · United States · 1 site
Registry update: 11 Jun 2026
NCT07071337
Recruiting
A Study of SKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic HR+/HER2- Breast Cancer Who Have Previously Failed Endocrine Therapy
Phase 3 · China · 2 sites
Registry update: 8 May 2026
NCT07105358
Recruiting
Vision Improvement Through Behavioral Rehabilitation And Neuroplasticity Training
Not applicable · United States · 1 site
Registry update: 14 Sept 2026
NCT07121595
Recruiting
Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma, PRECEDENT Trial
Phase 2 · United States · 1 site
Registry update: 31 Jul 2026
NCT07030400
Recruiting
Predictors of Health-Related QOL in Adults With CLL or Small Lymphocytic Lymphoma
Not applicable · United States · 1 site
Registry update: 1 Apr 2026
NCT06765109
Recruiting
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Phase 3 · Argentina, Austria, Australia, Belgium, Brazil, Canada, Switzerland, Chile, Czechia, Germany, Denmark, Spain, France, United Kingdom, Greece, Hong Kong, Hungary, Italy, Japan, South Korea, Mexico, Malaysia, Netherlands, Poland, Portugal, Singapore, Thailand, Taiwan, United States · 165 sites
Registry update: 30 Sept 2026
NCT07000084
Recruiting
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
Phase 3 · United States · 60 sites
Registry update: 2 Oct 2026
NCT07069712
Recruiting
A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
Phase 2 · Canada, China, Spain, United Kingdom, Georgia, Italy, Japan, Poland, Taiwan, United States · 59 sites
Registry update: 3 Nov 2026
NCT06942221
Recruiting
Digital Solutions in Heart Therapy (DIGNITY)
Not applicable · Switzerland · 1 site
Registry update: 2 Dec 2025
NCT06455332
Recruiting
Predictive Value of the Optic Nerve Involvement in Clinically Isolated Syndrome
Not applicable · France · 1 site
Registry update: 24 Aug 2025

Ordered by registry start date. Freshness and sponsorship never change the order.